In mouse models, a GM-CSF (Granulocyte-macrophage colony-stimulating factor)-secreting cancer vaccine (GVAX) improved the survival of mice engrafted with colon and pancreatic cancer cells when combined with the PD-1 blockade [41,42]. This evidence concerns the gene CSF2 and pancreatic neoplasm.